NCT03767426 The Effect of Sleep Deprivation and Recovery Sleep on Emotional Memory and Affective Reactivity
| NCT ID | NCT03767426 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beth Israel Deaconess Medical Center |
| Condition | Sleep Deprivation |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2019-03-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2019-03-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To further understand the impact of acute sleep deprivation and recovery sleep on the processing of emotional information the investigators will address and attempt to answer three questions, (i) how both undisturbed sleep and sleep deprivation affect the processing and retrieval of emotional information, (ii) what neural and psychophysiological mechanisms are associated with these behavioral effects, and (iii) to explore the ability of recovery sleep to reverse the effects of sleep deprivation. Together, these studies will provide a greater breadth and depth of knowledge concerning sleep's role in emotion processing and regulation. Given the growing societal tendency to view sleep as unproductive-foregoing it to lengthen work days and increase social opportunities- such knowledge would be of practical importance for understanding the role of sleep in healthy emotional functioning, particular for individuals experiencing periods of increased stress and emotional distress (e.g., new parents, hospital staff, or combat troops).
Eligibility Criteria
Inclusion Criteria: * willing and able to follow the protocol * willing and able to meet inclusion criteria for fMRI scanning * willing to refrain from alcohol and recreational drugs for the duration of the protocol * normal or corrected to normal vision is required Exclusion Criteria: * self-reported sleep disturbances * left-handedness or ambidexterity * a history of mental illness or neurological disorder * the use of any drugs that could affect either sleep or cognitive functioning (e.g., sleeping pills or antidepressants)
Contact & Investigator
Tony Cunningham, PhD
PRINCIPAL INVESTIGATOR
Beth Israel Deaconess Medical Center
Frequently Asked Questions
Who can join the NCT03767426 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Sleep Deprivation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03767426 currently recruiting?
Yes, NCT03767426 is actively recruiting participants. Contact the research team at acunnin4@bidmc.harvard.edu for enrollment information.
Where is the NCT03767426 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT03767426 clinical trial?
NCT03767426 is sponsored by Beth Israel Deaconess Medical Center. The principal investigator is Tony Cunningham, PhD at Beth Israel Deaconess Medical Center. The trial plans to enroll 100 participants.